A retrospective chart review to assess the safety profile of rapid daratumumab infusion in clinical practice
Latest Information Update: 08 Sep 2021
At a glance
- Drugs Daratumumab (Primary) ; Bortezomib; Dexamethasone; Lenalidomide; Pomalidomide
- Indications Amyloidosis; Multiple myeloma
- Focus Adverse reactions
- 24 Jan 2019 New trial record
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology